Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.007 USD 16.67% Market Closed
Market Cap: 22.8m USD
Have any thoughts about
Medivolve Inc?
Write Note

Medivolve Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medivolve Inc
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Medivolve Inc
OTC:MEDVF
Total Equity
-CA$15.8m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Andlauer Healthcare Group Inc
TSX:AND
Total Equity
CA$441m
CAGR 3-Years
67%
CAGR 5-Years
22%
CAGR 10-Years
N/A
WELL Health Technologies Corp
TSX:WELL
Total Equity
CA$767.7m
CAGR 3-Years
52%
CAGR 5-Years
138%
CAGR 10-Years
N/A
dentalcorp Holdings Ltd
TSX:DNTL
Total Equity
CA$1.7B
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
KDA Group Inc
XTSX:KDA
Total Equity
CA$14.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Healwell Al Inc
TSX:AIDX
Total Equity
CA$12.7m
CAGR 3-Years
386%
CAGR 5-Years
41%
CAGR 10-Years
N/A
No Stocks Found

Medivolve Inc
Glance View

Market Cap
22.8m USD
Industry
Health Care

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

MEDVF Intrinsic Value
0.004 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is Medivolve Inc's Total Equity?
Total Equity
-15.8m CAD

Based on the financial report for Dec 31, 2023, Medivolve Inc's Total Equity amounts to -15.8m CAD.

What is Medivolve Inc's Total Equity growth rate?
Total Equity CAGR 3Y
-16%

The average annual Total Equity growth rates for Medivolve Inc have been -16% over the past three years .

Back to Top